Macrogen KRX:038290KOSDAQ
마크로젠 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days2
DART filings, 7 days0
Articles tracked11since Sep 11
In Q2 2026, Macrogen reported revenue of ₩51.0bn, up 4.1% year on year, and operating profit of ₩698m. Macrogen (마크로젠) appeared in 2 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 27 with 2 articles.
Filing signals Turnaround Insider buying Screener
Macrogen quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩51.0bn | +4.1% | ₩698m margin 1.4% | ₩4.3bn |
| Q1 2026 | ₩45.3bn | +10.6% | −₩509m margin −1.1% | −₩827m |
| Q4 2025 derived | ₩56.3bn | +37.3% | ₩3.6bn margin 6.5% | ₩3.1bn |
| Q3 2025 | ₩49.1bn | +48.7% | ₩1.1bn margin 2.3% | ₩2.1bn |
| Q2 2025 | ₩49.0bn | +62.4% | −₩1.5bn margin −3.1% | −₩2.3bn |
| Q1 2025 | ₩41.0bn | +29.5% | −₩3.0bn margin −7.4% | −₩3.2bn |
| Q4 2024 derived | ₩41.0bn | +11.0% | −₩3.1bn margin −7.5% | ₩744m |
| Q3 2024 | ₩33.0bn | +2.2% | −₩589m margin −1.8% | −₩3.5bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Macrogen top stories 2 weeks, by number of outlets
- 1
Latest Macrogen news Korean headlines
-
메디쏠라·종근당건강·마크로젠, 삼성 헬스서 맞춤형 장 건강 챌린지 운영
1 more on this story · 1 outlets
- 메디쏠라·종근당건강·마크로젠, 삼성 헬스에서 ‘나만의 장 건강 챌린지’ 선보여바이오타임즈 · Oct 27 10:00
-
마크로젠 "전장유전체 분석, 수일→수시간 시대로"
1 more on this story · 1 outlets
- 전장유전체 분석 '수일→수시간'…마크로젠, 로슈 '악셀리오스 1' 가동베타뉴스 · Oct 15 15:52